Over the past 20 years, Novartis has continued to address chronic myeloid leukemia (CML) innovation with a relentless commitment to patients with CML who continue to face unmet needs.
Learn more: https://bit.ly/2WLSz6Q
©2021 Novartis AG
Source Novartis YouTube
